0001209191-22-031994.txt : 20220525 0001209191-22-031994.hdr.sgml : 20220525 20220525195432 ACCESSION NUMBER: 0001209191-22-031994 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220524 FILED AS OF DATE: 20220525 DATE AS OF CHANGE: 20220525 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pruzanski Mark CENTRAL INDEX KEY: 0001559569 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38692 FILM NUMBER: 22964608 MAIL ADDRESS: STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC. STREET 2: 18 DESBROSSES ST. CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Equillium, Inc. CENTRAL INDEX KEY: 0001746466 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821554746 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 105 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 412-5302 MAIL ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 105 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-24 0 0001746466 Equillium, Inc. EQ 0001559569 Pruzanski Mark 2223 AVENIDA DE LA PLAYA, SUITE 105 LA JOLLA CA 92037 1 0 0 0 Stock Option (right to buy) 2.59 2022-05-24 4 A 0 20000 0.00 A 2032-05-24 Common Stock 20000 20000 D The option vests in twelve equal monthly installments commencing on the grant date of May 24, 2022, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date. /s/ Jason A. Keyes, Attorney-in-Fact for Mark Pruzanski 2022-05-25